Patents by Inventor Michael James Francis

Michael James Francis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110070256
    Abstract: The present invention discloses novel proteins, e.g., antigens, from Piscirickettsia salmonis. The present invention further discloses nucleic acids that encode these proteins. The present invention also discloses the use of the proteins, e.g., antigens, and nucleic acids to prepare vaccines against salmonid rickettsial septicemia (SRS). The present invention also discloses vaccines that can be used to protect fish from Piscirickettsia salmonis, as well as other pathogens. In addition, the present invention discloses methods of using the vaccines of the present invention to protect fish from SRS as well as from other pathogenic diseases.
    Type: Application
    Filed: September 20, 2010
    Publication date: March 24, 2011
    Applicant: INTERVET INTERNATIONAL B.V.
    Inventors: DAVID FRANCIS KIRKE, MICHAEL JAMES FRANCIS
  • Publication number: 20100330113
    Abstract: The present invention discloses novel proteins, e.g., antigens. The present invention further discloses nucleic acids that encode these proteins. The present invention also discloses the use of the proteins, e.g., antigens, and nucleic acids to prepare vaccines against salmonid rickettsial septicemia (SRS). The present invention also discloses vaccines that can be used to protect fish from Piscirickettsia salmonis, as well as other pathogens. In addition, the present invention discloses methods of using the vaccines of the present invention to protect fish from SRS as well as from other pathogenic diseases.
    Type: Application
    Filed: April 20, 2010
    Publication date: December 30, 2010
    Inventors: David Francis Kirke, Michael James Francis
  • Patent number: 7811583
    Abstract: The present invention discloses novel proteins, e.g., antigens, from Piscirickettsia salmonis. The present invention further discloses nucleic acids that encode these proteins. The present invention also discloses the use of the proteins, e.g., antigens, and nucleic acids to prepare vaccines against salmonid rickettsial septicemia (SRS). The present invention also discloses vaccines that can be used to protect fish from Piscirickettsia salmonis, as well as other pathogens. In addition, the present invention discloses methods of using the vaccines of the present invention to protect fish from SRS as well as from other pathogenic diseases.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: October 12, 2010
    Assignee: Intervet International B.V.
    Inventors: David Francis Kirke, Michael James Francis
  • Publication number: 20090162391
    Abstract: The present invention discloses novel proteins, e.g., antigens, from Piscirickettsia salmonis. The present invention further discloses nucleic acids that encode these proteins. The present invention also discloses the use of the proteins, e.g., antigens, and nucleic acids to prepare vaccines against salmonid rickettsial septicemia (SRS). The present invention also discloses vaccines that can be used to protect fish from Piscirickettsia salmonis, as well as other pathogens. In addition, the present invention discloses methods of using the vaccines of the present invention to protect fish from SRS as well as from other pathogenic diseases.
    Type: Application
    Filed: December 18, 2008
    Publication date: June 25, 2009
    Inventors: David Francis Kirke, Michael James Francis
  • Patent number: 5864008
    Abstract: A peptide and veterinarily acceptable salts thereof are disclosed which comprise an amino acid sequence which is derived from foot-and-mouth disease virus (FMDV). The peptide is independent within the FMDV structure of a B-cell epitode and is capable of eliciting T-cell help in an animal susceptible to FMDV infection for production of antibody against an antigen. Optionally, an amino acid in the sequence may be replaced by another amino acid which does not affect the function of the sequence to elicit T-cell help.
    Type: Grant
    Filed: July 28, 1992
    Date of Patent: January 26, 1999
    Inventors: Stephen James, David John Rowlands, Michael James Francis